Summary:
A MULTICENTER, DOUBLE-BLIND, PLACEBOCONTROLLED
STUDY EVALUATING THE EFFICACY,
SAFETY, TOLERABILITY, AND PHARMACOKINETICS
OF BREXANOLONE IN THE TREATMENT OF
ADOLESCENT FEMALE SUBJECTS WITH
POSTPARTUM DEPRESSION
Qualified Participants Must:
• Be 15-17 years old
• has gave birth within the past 6 months
Qualified Participants May Receive:
Compensation for time and travel